FACTORS RELATED TO RESULTS IN SURPORTIVE TREATMENT OF THYROID-ASSOCIATED OPHTHALMOPATHY BY ACUPUNCTURE THERAPY

Thị Thanh Tú Nguyễn1,, Tiến Đạt Lê1
1 HMU

Main Article Content

Abstract

Objective: This study aimed to describe some factors related to the results  in the supportive treatment Thyroid-associated Ophthalmopathy by acupuncture therapy. Subjects and Method: open clinical interventional study, comparison of the data before and after treatment on 30 patients diagnosed with Thyroid-associated Ophthalmopathy. Results: The study results showed that after treatment, the improvement in ocular protrusion ≥ 2mm of the non-smoking group was 18.18%,  higher than that of the smoking group of 12.5%. The improvement in Clinical activity score > 2mm of the non-smoking group was 27.27% higher than that of the smokers group of 25%. Patients with FT4 ≤ 24 pmol/l (normal thyroid function) had results in improving the degree of protrusion ≥ 2mm better than in the hyperthyroid group. In the group with less than 12 months of disease, the improvement in the degree of protrusion (reduction of ≥ 2mm) was better than that of the group with the disease over 12 months.

Article Details

References

Cục quản lý Khám chữa bệnh. Quy trình chuyên môn chẩn đoán, điều trị và chăm sóc người bệnh Basedow.
2. Hứa Căn Quý, Ngô Nghệ Quân, Thịnh Văn, Chu Tú Ảnh, Lã Phàm. Mối tương quan giữa các yếu tố ảnh hưởng lên thị giác trên bệnh nhãn khoa có liên quan tới tuyến giáp. Tạp chí khoa học và nhãn khoa Trung Quốc. 2013; 015(002):P.98-1031 1
3. Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158(3):273-285.
4. Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol. 2021;185(4):G43-G67.
5. JPfeilschifter, R Ziegler. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. 1996 Oct;45(4):477-81
6. WP Mack, GO Stasior. The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. 1999;15(4):260-71
7. Y Yamano 1, J Takamatsu, et al. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease. (8):769-73